Merck Financials
6MK Stock | EUR 97.10 3.70 3.96% |
Merck |
Understanding current and past Merck Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Merck's financial statements are interrelated, with each one affecting the others. For example, an increase in Merck's assets may result in an increase in income on the income statement.
Merck Stock Summary
Merck competes with Johnson Johnson, Roche Holding, Amgen, and Bayer AG. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK DL operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 73000 people.Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | US58933Y1055 |
Business Address | 2000 Galloping Hill |
Sector | Healthcare |
Industry | Drug Manufacturers—General |
Benchmark | Dow Jones Industrial |
Website | www.merck.com |
Phone | 908 740 4000 |
Currency | EUR - Euro |
You should never invest in Merck without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Merck Stock, because this is throwing your money away. Analyzing the key information contained in Merck's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Merck Key Financial Ratios
There are many critical financial ratios that Merck's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Merck reports annually and quarterly.Merck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Merck's current stock value. Our valuation model uses many indicators to compare Merck value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck competition to find correlations between indicators driving Merck's intrinsic value. More Info.Merck Co is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.35 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck Co is roughly 2.88 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck's earnings, one of the primary drivers of an investment's value.Merck Systematic Risk
Merck's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merck volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Merck correlated with the market. If Beta is less than 0 Merck generally moves in the opposite direction as compared to the market. If Merck Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merck is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merck is generally in the same direction as the market. If Beta > 1 Merck moves generally in the same direction as, but more than the movement of the benchmark.
Merck November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Merck help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merck Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merck Co based on widely used predictive technical indicators. In general, we focus on analyzing Merck Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merck's daily price indicators and compare them against related drivers.
Information Ratio | (0.17) | |||
Maximum Drawdown | 5.61 | |||
Value At Risk | (2.28) | |||
Potential Upside | 1.72 |
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |